Clinical trial
Evaluating Genetic Modifiers of Cutaneous Neurofibromas in Adults With Neurofibromatosis Type 1
NCT04941027 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating Genetic Modifiers of Cutaneous Neurofibromas in Adults With Neurofibromatosis Type 1
- Lead sponsor
- Stanford University
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 7, 2021
- Completion date
- November 24, 2025
- Enrollment
- 1,046 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.